Isomorphic Labs, the UK-based biotech spinoff of Google DeepMind, is set to begin human trials of drugs designed by its Nobel ...

AlphaFold can predict these structures without running experiments. In July 2021, researchers gained access to hundreds of thousands of these AI-predicted structures virtually overnight. Yet, to date, ...

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting ...

Google DeepMind cofounder and CEO Demis Hassabis and John Jumper, a senior researcher at the company, shared the 2024 Nobel Prize for Chemistry for their work on AlphaFold, an AI model that predicts ...

AlphaFold arrived as a technical moonshot that suddenly made protein structures feel like software rather than secrets of nature, and five years on it has rewired how laboratories plan experiments, ...

This article sets out why the UK must move now to lead the convergence that will define the next generation of medicines.

Domestic researchers have made significant progress toward developing artificial intelligence (AI)-based antibody drugs that ...

We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.